News und Analysen

It's been a rough past 12 months for UnitedHealth Group (NYSE: UNH), with the stock price down nearly 34% (through Jan. 20). This is not-so-great news for a company that's had its fair share of

There's nothing quite like making money while you sleep. And investing in dividend stocks is a great way to do that. However, with so many dividend payers, it can be hard to know which one to pick.

Explore the exciting world of Insulet (NASDAQ: PODD) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

Medtronic (NYSE: MDT) is coming off a strong year. The company performed well in 2025, despite some threats to its business, including the impact of tariffs on its operations.

As 2026 begins, the

In 2025, UnitedHealth Group (NYSE: UNH) faced a notable increase in medical costs amid other challenges, forcing management to cut its earnings guidance in April before withdrawing it completely a

UnitedHealth Group (NYSE: UNH) is coming off a brutal 2025, when its stock lost a staggering 35% in value, despite the markets enjoying a fairly strong year with the S&P 500 climbing by 16%

The S&P 500 marched on to its third consecutive annual gain in 2025, but one of the country's market leaders missed out on this momentum. I'm talking about UnitedHealth Group (NYSE: UNH), the U.S.'

The stock of healthcare company Neogen (NASDAQ: NEOG) was the very picture of financial health on Thursday, as its share price ballooned by over 31% that trading session. Investors were clearly

This is the time of year when market professionals and investors alike pore over lists of top analyst stock picks. One big company that appeared in such a lineup was UnitedHealth (NYSE: UNH), and in

Stryker (NYSE: SYK) stock is hopping Tuesday morning, up 3.2% through 11:45 a.m. ET, after Raymond James analyst Jayson Bedford called the company "one of the highest quality stocks in large cap

Shares of AngioDynamics (NASDAQ: ANGO) were sinking 13.1% as of 11:02 a.m. ET. The sell-off came after the medical technology company announced its third-quarter results before the market open.

Corey J Manley, EVP & Chief Legal/Admin Officer at Omnicell (NASDAQ:OMCL), executed an open-market sale of 6,106 shares for $243,629.40 on Dec. 3, 2025, as reported in the SEC Form 4 filing.

UnitedHealth Group (NYSE: UNH) has long been one of the premier health insurance companies in the United States, but it and its stock are not unfamiliar with controversy or volatility. It's been a

Most dividend investors are looking not just for a high yield, but also for a company that can reliably support that yield over the long term. It is harder to find than you may think, but not

Explore the exciting world of Medtronic (NYSE: MDT) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million

A $1,000 investment will buy you nearly 20 shares of Bristol Myers Squibb (NYSE: BMY) and about 10 shares of Medtronic (NYSE: MDT). For dividend lovers, they should both be appealing buy-and-hold